Cannabidiol

Overview

Cannabidiol is a phytocannabinoid derived from the cannabis plant that does not induce psychoactive effects. It is primarily used to treat certain forms of epilepsy and is being investigated for its potential to alleviate various conditions involving pain and inflammation.

API suppliers (4)

Suppliers of Cannabidiol backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• YUNNAN HANSU BIOTECHNOLOGY CO LTD2 active DMF
• MediPharma Inc.USA1 active DMF
• MediPharma Inc.USA1 active DMF
• MediPharma Inc.USA1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Cannabidiol expires 1 Mar 2041 and exclusivity 30 Jul 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas